The Daily Overview on MSN

Eli Lilly closes in on a deal to buy biotech Ventyx

Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...

Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines

Notably, the paper also includes simulation studies outlining when dDRTC is most effective, positioning it as a practical ...